Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams

This study was designed to investigate dosimetric variations between proton plans with (PPW) and without (PPWO), a compensator for whole brain radiotherapy (WBRT). The retrospective study on PPW and PPWO in Eclipse and XiO systems and photon plans (XP) using controlled segments in Pinnacle system was performed on nine pediatric patients for craniospinal irradiations. DVHs and derived metrics, such as the homogeneity index (HI), the doses to 2%(D2%) and 5%(D5%) volumes, and mean dose (Dmean) of the whole brain (i.e., PTV), and the organs at risk (OARs) such as lens and skull, were obtained. The PPW plans from both Eclipse and XiO systems uncovered the following advantages: (1) encompassing a cribriform plate area with the 100% isodose line was better than either PPWO or XP, according to calculated two‐dimensional distributions of one patient; (2) the mean value of D5% for lens was reduced to 23.6% of DP from 54.1% for PPWO or 41.6% for XP; and (3) the mean value of Dmean for skull was reduced to 94.8% of DP from either 98.4% for PPWO or 98.3% for XP. However, the PPW plans also exposed several disadvantages including: (1) the HI of PTV increased to 7.7 from 4.7 for PPWO or 3.7 for XP; (2) D2% to PTV increased to 108.8% of DP from 104.8% for PPWO or 105.1% for XP; and (3) D5% to the skull increased to 104.9% of DP from 101.6% for PPWO or 103.4% of for XP. One‐half of the observed variations were caused by different penumbra on lateral profiles and distal fall‐off depth doses of protons in Eclipse and XiO. Because the utilization on the sharp proton distal fall‐off was limited for WBRT, the difference between PPW and PPWO or XP indicated no distinguishable improvement by using a compensator in proton plans. PACS number: 87.55.‐x

[1]  Daniel W. Miller,et al.  Ion stopping powers and CT numbers. , 2010, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[2]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[3]  H. Friedman,et al.  Subfrontal recurrence of medulloblastoma. , 1992, AJNR. American journal of neuroradiology.

[4]  M Bues,et al.  Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. , 2004, International journal of radiation oncology, biology, physics.

[5]  J. Cox,et al.  Comparison of surface doses from spot scanning and passively scattered proton therapy beams , 2009, Physics in medicine and biology.

[6]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[7]  Dong Wook Kim,et al.  Prediction of output factor, range, and spread-out bragg peak for proton therapy. , 2011, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[8]  Alfred R. Smith,et al.  Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? , 2005, International journal of radiation oncology, biology, physics.

[9]  Roberto Orecchia,et al.  Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. , 2009, Cancer treatment reviews.

[10]  Robert J. Schneider,et al.  Multiple Coulomb scattering of 160 MeV protons , 1993 .

[11]  Hsiao-Ming Lu,et al.  Optimization of current modulation function for proton spread-out Bragg peak fields. , 2006, Medical physics.

[12]  Harold O. Wyckoff,et al.  International Commission ON Radiation Units and Measurements (ICRU). , 1974, The American journal of roentgenology, radium therapy, and nuclear medicine.

[13]  M Goitein,et al.  A pencil beam algorithm for proton dose calculations. , 1996, Physics in medicine and biology.

[14]  Zuofeng Li,et al.  Prescribing, Recording, and Reporting Proton-Beam Therapy , 2009 .

[15]  E. Pedroni,et al.  Dose calculation models for proton treatment planning using a dynamic beam delivery system: an attempt to include density heterogeneity effects in the analytical dose calculation. , 1999, Physics in medicine and biology.

[16]  K. Hogstrom,et al.  Improving the therapeutic ratio of craniospinal irradiation in medulloblastoma. , 1985, International journal of radiation oncology, biology, physics.

[17]  J. Chow,et al.  Surface dosimetry for oblique tangential photon beams: a Monte Carlo simulation study. , 2007, Medical physics.

[18]  Tae-Suk Suh,et al.  Evaluation of surface and build-up region dose for intensity-modulated radiation therapy in head and neck cancer. , 2005, Medical physics.

[19]  R. Mohan,et al.  Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. , 2003, International Journal of Radiation Oncology, Biology, Physics.

[20]  Uwe Schneider,et al.  Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. , 2002, International journal of radiation oncology, biology, physics.

[21]  N. Tarbell,et al.  Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique. , 2008, International journal of radiation oncology, biology, physics.

[22]  C. Allgower,et al.  Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking. , 2008, Medical physics.

[23]  B. Bannach,et al.  The role of CT simulation in whole-brain irradiation. , 1999, International journal of radiation oncology, biology, physics.